(Q35555698)

English

Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome

scientific article published on 7 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome (English)

1 reference

Europe PubMed Central

8 August 2017

1 reference

based on heuristic

inferred from title

author name string

Gottenberg JE

1

1 reference

Europe PubMed Central

8 August 2017

Busson M

2

1 reference

Europe PubMed Central

8 August 2017

Cohen-Solal J

3

1 reference

Europe PubMed Central

8 August 2017

Lavie F

4

1 reference

Europe PubMed Central

8 August 2017

Abbed K

5

1 reference

Europe PubMed Central

8 August 2017

Kimberly RP

6

1 reference

Europe PubMed Central

8 August 2017

Sibilia J

7

1 reference

Europe PubMed Central

8 August 2017

Mariette X

8

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

7 January 2005

1 reference

Europe PubMed Central

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

8 August 2017

64

1 reference

Europe PubMed Central

8 August 2017

7

1 reference

Europe PubMed Central

8 August 2017

1050-1055

1 reference

Europe PubMed Central

8 August 2017

Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

BAFF: a fundamental survival factor for B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Elevated serum beta-2-microglobulin--a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Treatment of primary Sjögren's syndrome with hydroxychloroquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Structure, function, and diversity of class I major histocompatibility complex molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Primary Sjögren's syndrome--clinical and laboratory markers of disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Elevated Salivary and Synovial Fluid β 2 -Microglobulin in Sjogren's Syndrome and Rheumatoid Arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

12 July 2018

Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

Reappraisal of serum beta2-microglobulin as marker of GFR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755548

26 September 2018

The diagnosis value of beta 2-microglobulin and immunoglobulins in primary Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity: activation of caspase-3 and nuclear factor-kappaB

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predictive of renal involvement in patients with primary Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome measures in Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β2-microglobulin as a potential initiator of inflammatory responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary findings in patients with primary Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary Sjögren's syndrome in the North East of England: a long-term follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15640273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2004.030643

1 reference

Europe PubMed Central

8 August 2017

release_lyrcuegdvfh37hoszmdi5ytt7a

1 reference

https://api.fatcat.wiki/v0/release/lyrcuegdvfh37hoszmdi5ytt7a

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35555698&oldid=1841612594"